Literature DB >> 27240700

Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy.

Thibault De Maesschalck1, Nicolas Dulguerov1, Francesca Caparrotti2, Paolo Scolozzi3, Cristina Picardi2, Nicolas Mach4, Nikolaos Koutsouvelis2, Pavel Dulguerov5.   

Abstract

BACKGROUND: Modern techniques of radiotherapy are supposed to decrease the incidence of osteoradionecrosis of the mandible (ORNM). The purpose of this study was to compare the incidence of ORNM after intensity-modulated radiotherapy (IMRT) in comparison to conventional 3D conformal radiotherapy techniques (conventional RT).
METHODS: We conducted a retrospective study of consecutive unselected patients treated in a single institution between 2002 and 2012. To minimize confounding effects, only patients with oropharyngeal carcinoma without surgery of the primary site were included.
RESULTS: The cohorts included 145 patients in the conventional RT group and 89 patients in the IMRT group. Total incidence rate of ORNM was similar for both groups with rates of 11% versus 10% (n = 16 for conventional RT and n = 9 for IMRT; p = 1.0). Subanalysis revealed more ORNM in T4 classified lesions with IMRT (p = .007). Analysis of different risk factors showed no statistically significant difference between ORNM and no-ORNM patients.
CONCLUSION: We found no reduction in ORNM with IMRT.
© 2016 Wiley Periodicals, Inc. Head Neck 38: 1708-1716, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; head and neck; intensity-modulated radiotherapy (IMRT); oropharynx; osteoradionecrosis; radiotherapy

Mesh:

Year:  2016        PMID: 27240700     DOI: 10.1002/hed.24505

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.

Authors:  Theodoros N Teknos; J Grecula; A Agrawal; M O Old; E Ozer; R Carrau; S Kang; J Rocco; D Blakaj; V Diavolitsis; B Kumar; P Kumar; Q Pan; M Palettas; L Wei; R Baiocchi; P Savvides
Journal:  Invest New Drugs       Date:  2018-12-19       Impact factor: 3.850

2.  Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.

Authors: 
Journal:  Radiother Oncol       Date:  2017-07-18       Impact factor: 6.280

3.  Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma.

Authors:  Hikaru Kubota; Daisuke Miyawaki; Naritoshi Mukumoto; Takeaki Ishihara; Megumi Matsumura; Takumi Hasegawa; Masaya Akashi; Naomi Kiyota; Hirotaka Shinomiya; Masanori Teshima; Ken-Ichi Nibu; Ryohei Sasaki
Journal:  Radiat Oncol       Date:  2021-01-05       Impact factor: 3.481

Review 4.  The Potential Therapeutic Role of Mesenchymal Stem Cells-Derived Exosomes in Osteoradionecrosis.

Authors:  Yuetian Li; Xinyue Wang; Yu Pang; Shuangcheng Wang; Meng Luo; Bo Huang
Journal:  J Oncol       Date:  2021-12-02       Impact factor: 4.375

Review 5.  Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis : A systematic review and meta-analysis.

Authors:  Panagiotis Balermpas; Janita E van Timmeren; David J Knierim; Matthias Guckenberger; Ilja F Ciernik
Journal:  Strahlenther Onkol       Date:  2022-01-14       Impact factor: 3.621

6.  Potential role of post-treatment follow-up FDG-PET CT to detect mandibular osteoradionecrosis: A case report.

Authors:  Masaya Akashi; Satoshi Wanifuchi; Junya Kusumoto; Megumi Kishimoto; Yasumasa Kakei; Kazunobu Hashikawa; Takahide Komori
Journal:  Mol Clin Oncol       Date:  2017-11-02

7.  The Efficacy of a Custom-Made Mouthpiece With Spacer to Reduce Osteoradionecrosis in Carbon-Ion Radiation Therapy for Tongue-Base Tumor.

Authors:  Hiroaki Ikawa; Masashi Koto; Daniel K Ebner; Kazuhiko Hayashi; Ryo Takagi; Morio Tonogi; Takeshi Nomura; Hiroshi Tsuji; Tadashi Kamada
Journal:  Adv Radiat Oncol       Date:  2018-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.